AUTH/3382/9/20: Complainant v Chugai — Granocyte showreel YouTube video (No breach)

📅 2020 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/3382/9/20
CompanyChugai Pharma UK Limited
ProductGranocyte (lenograstim)
MaterialGranocyte showreel YouTube video (24 seconds; music only; screenshots of draft sales aid)
AllegationsPromotion of a POM to the public; missing prescribing information; not recertified every two years; high standards
Platform / accessYouTube “unlisted” link; unexpectedly indexed by Google
Applicable Code year2019
Clauses considered4.1, 9.1, 14.5, 26.1
Panel decisionNo breach of Clauses 4.1, 9.1, 14.5, 26.1
Complaint received10 September 2020
Case completed29 March 2021
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A UK health professional complained about a short YouTube video (dated 2014; uploaded 2015) that appeared to promote Granocyte (lenograstim), a prescription-only medicine.
  • The complainant alleged it had been left publicly available for ~5 years, had not been recertified every two years, and was missing prescribing information.
  • Chugai said the video was created and uploaded by a former medical communications agency after the relationship ended, as a showreel to demonstrate the agency’s capabilities to potential clients.
  • The video (24 seconds, music only) showed screenshots of a draft Granocyte sales aid; product claims were visible.
  • The agency said the YouTube upload was set as an unlisted link intended to be shared only with named individuals; it could not be found via standard YouTube search.
  • The video became discoverable because it was unexpectedly indexed by Google (e.g., searching “Granocyte” and selecting Google’s “videos” results).
  • After the complaint, the agency removed the video and associated page content and Google links.
⚖️

Outcome

  • No breach of the Code was ruled.
  • The Panel considered the video to be an agency showreel, not promotional material being used by Chugai, and therefore not material covered by the Code in the way alleged.
  • The Panel accepted, on the balance of probabilities, that the video was not intended for general access and became searchable due to Google indexing.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training